The relapse rate of acute myeloid leukemia after complete remission ranges from 10% to 30%. Depending on the degree of the disease, patients are categorized into low-risk, intermediate-risk and high-risk types. 1. Low-risk type: patients can be cured by chemotherapy, the cure rate of this disease is 80%, and the relapse rate after complete remission is 20%. After treatment, patients need to go to the hospital for regular bone marrow tests to avoid recurrence. 2. Intermediate-risk type: The success rate of transplantation for patients with intermediate-risk type is 70% after chemotherapy or hematopoietic stem cell transplantation. Patients with good response to chemotherapy can continue to choose chemotherapy, while patients with poor chemotherapy results can be treated with hematopoietic stem cell transplantation. 3. High-risk type: For high-risk patients, doctors usually choose hematopoietic stem cell transplantation for treatment, and the recurrence rate is between 10% and 20%. Patients are advised to go to the hospital for regular checkups to avoid complications arising from hematopoietic stem cell transplantation. If AML relapses after complete remission, patients need to go to the hospital for follow-up and receive timely treatment under the guidance of a physician.